Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with […]